Dow Down 0.32% Nasdaq Down 0.62%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
1.40 Down 0.11(7.28%) Apr 29, 4:00PM EDT
|After Hours : 1.39 Down 0.01 (0.71%) Apr 29, 4:00PM EDT
Prev Close:1.51
Open:1.51
Bid:1.35 x 100
Ask:1.82 x 500
1y Target Est:5.00
Beta:1.00274
Next Earnings Date:N/A
Day's Range:1.36 - 1.51
52wk Range:1.28 - 12.55
Volume:515,647
Avg Vol (3m):450,844
Market Cap:142.44M
P/E (ttm):N/A
EPS (ttm):-1.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBODown 7.28%142.44M
AGENDown 8.33%304.58M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):79.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback